STOCK TITAN

[Form 4] Exelon Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 insider activity – Exelon Corporation (EXC): On 06/30/2025 director Bryan K. Segedi acquired 954 deferred stock units of Exelon common stock at $43.25 each through the Exelon Corp. Directors Deferred Stock Unit Plan. The purchase increased his indirect holdings to 6,483 units, a figure that already includes 51 shares accumulated via dividend reinvestment. No shares were sold and no derivative positions were reported.

The transaction is valued at roughly $41k, immaterial to Exelon’s overall share count, but may signal incremental insider confidence. There are no indications of significant strategic shifts, option exercises, or complex hedging instruments in this filing.

Attività insider Modulo 4 – Exelon Corporation (EXC): Il 30/06/2025 il direttore Bryan K. Segedi ha acquisito 954 unità azionarie differite di azioni ordinarie Exelon al prezzo di 43,25$ ciascuna tramite il Piano di Unit Stock Differite per i Direttori di Exelon Corp. L'acquisto ha portato la sua partecipazione indiretta a 6.483 unità, cifra che include già 51 azioni accumulate tramite il reinvestimento dei dividendi. Non sono state vendute azioni né segnalate posizioni derivati.

La transazione ha un valore di circa 41.000$, insignificante rispetto al totale delle azioni di Exelon, ma potrebbe indicare una crescente fiducia degli insider. Non ci sono segnali di cambiamenti strategici rilevanti, esercizi di opzioni o strumenti di copertura complessi in questa comunicazione.

Actividad de insiders en el Formulario 4 – Exelon Corporation (EXC): El 30/06/2025, el director Bryan K. Segedi adquirió 954 unidades de acciones diferidas de acciones comunes de Exelon a 43,25$ cada una a través del Plan de Unidades de Acciones Diferidas para Directores de Exelon Corp. La compra aumentó su participación indirecta a 6,483 unidades, cifra que ya incluye 51 acciones acumuladas mediante reinversión de dividendos. No se vendieron acciones ni se reportaron posiciones en derivados.

La transacción tiene un valor aproximado de 41.000$, insignificante en relación al total de acciones de Exelon, pero podría señalar una confianza incremental de los insiders. No hay indicios de cambios estratégicos significativos, ejercicios de opciones o instrumentos de cobertura complejos en esta presentación.

Form 4 내부자 거래 – Exelon Corporation (EXC): 2025년 6월 30일, 이사 Bryan K. Segedi가 Exelon 일반주식의 954개의 이연 주식 단위를 주당 43.25달러에 Exelon Corp. 이사 이연 주식 단위 계획을 통해 취득했습니다. 이 거래로 그의 간접 보유량은 6,483 단위로 증가했으며, 이 중 51주는 배당금 재투자를 통해 이미 축적된 주식입니다. 주식 매도나 파생상품 포지션 보고는 없었습니다.

거래 가치는 약 41,000달러로 Exelon의 전체 주식 수에 비해 미미하지만 내부자의 신뢰가 점진적으로 증가하고 있음을 시사할 수 있습니다. 이번 보고서에서는 중요한 전략적 변화, 옵션 행사 또는 복잡한 헤징 수단에 대한 징후는 없습니다.

Activité des initiés Formulaire 4 – Exelon Corporation (EXC) : Le 30/06/2025, le directeur Bryan K. Segedi a acquis 954 unités d’actions différées d’actions ordinaires Exelon au prix de 43,25$ chacune via le Plan d’Unités d’Actions Différées pour les Administrateurs d’Exelon Corp. Cet achat a porté ses avoirs indirects à 6 483 unités, chiffre incluant déjà 51 actions accumulées par réinvestissement des dividendes. Aucune action n’a été vendue et aucune position sur dérivés n’a été déclarée.

La transaction est estimée à environ 41 000$, ce qui est négligeable par rapport au nombre total d’actions d’Exelon, mais pourrait indiquer une confiance accrue des initiés. Aucun signe de changements stratégiques majeurs, d’exercices d’options ou d’instruments de couverture complexes n’apparaît dans ce dépôt.

Formular 4 Insider-Aktivität – Exelon Corporation (EXC): Am 30.06.2025 erwarb Direktor Bryan K. Segedi 954 aufgeschobene Aktienanteile von Exelon-Stammaktien zu je 43,25$ über den Exelon Corp. Directors Deferred Stock Unit Plan. Der Kauf erhöhte seine indirekten Bestände auf 6.483 Einheiten, wobei bereits 51 Aktien durch Dividenden-Reinvestitionen enthalten sind. Es wurden keine Aktien verkauft und keine Derivatpositionen gemeldet.

Die Transaktion hat einen Wert von etwa 41.000$, was im Verhältnis zur Gesamtzahl der Exelon-Aktien unerheblich ist, aber auf ein zunehmendes Insidervertrauen hinweisen könnte. Es gibt keine Hinweise auf bedeutende strategische Veränderungen, Optionsausübungen oder komplexe Absicherungsinstrumente in dieser Meldung.

Positive
  • None.
Negative
  • None.

Insights

TL;DR – Small insider buy; minimal direct impact on valuation.

Segedi’s purchase of 954 deferred stock units is financially modest for a multi-billion-dollar utility like Exelon, representing well under 0.01 % of shares outstanding. Because the units were acquired under a standing director compensation plan, the filing largely reflects routine equity accrual rather than an opportunistic open-market buy. While insider alignment is generally viewed positively, the scale makes the event neutral for most valuation models and unlikely to move the stock.

TL;DR – Routine deferred stock grant, underscores board equity alignment.

The deferred stock unit plan channels a portion of director compensation into equity, aligning board interests with shareholders over the long term. Segedi’s holdings now stand at 6,483 units, a reasonable stake that encourages oversight without granting outsized influence. Absence of sales or derivative activity removes potential conflict signals. Governance-wise, the filing is standard and non-controversial.

Attività insider Modulo 4 – Exelon Corporation (EXC): Il 30/06/2025 il direttore Bryan K. Segedi ha acquisito 954 unità azionarie differite di azioni ordinarie Exelon al prezzo di 43,25$ ciascuna tramite il Piano di Unit Stock Differite per i Direttori di Exelon Corp. L'acquisto ha portato la sua partecipazione indiretta a 6.483 unità, cifra che include già 51 azioni accumulate tramite il reinvestimento dei dividendi. Non sono state vendute azioni né segnalate posizioni derivati.

La transazione ha un valore di circa 41.000$, insignificante rispetto al totale delle azioni di Exelon, ma potrebbe indicare una crescente fiducia degli insider. Non ci sono segnali di cambiamenti strategici rilevanti, esercizi di opzioni o strumenti di copertura complessi in questa comunicazione.

Actividad de insiders en el Formulario 4 – Exelon Corporation (EXC): El 30/06/2025, el director Bryan K. Segedi adquirió 954 unidades de acciones diferidas de acciones comunes de Exelon a 43,25$ cada una a través del Plan de Unidades de Acciones Diferidas para Directores de Exelon Corp. La compra aumentó su participación indirecta a 6,483 unidades, cifra que ya incluye 51 acciones acumuladas mediante reinversión de dividendos. No se vendieron acciones ni se reportaron posiciones en derivados.

La transacción tiene un valor aproximado de 41.000$, insignificante en relación al total de acciones de Exelon, pero podría señalar una confianza incremental de los insiders. No hay indicios de cambios estratégicos significativos, ejercicios de opciones o instrumentos de cobertura complejos en esta presentación.

Form 4 내부자 거래 – Exelon Corporation (EXC): 2025년 6월 30일, 이사 Bryan K. Segedi가 Exelon 일반주식의 954개의 이연 주식 단위를 주당 43.25달러에 Exelon Corp. 이사 이연 주식 단위 계획을 통해 취득했습니다. 이 거래로 그의 간접 보유량은 6,483 단위로 증가했으며, 이 중 51주는 배당금 재투자를 통해 이미 축적된 주식입니다. 주식 매도나 파생상품 포지션 보고는 없었습니다.

거래 가치는 약 41,000달러로 Exelon의 전체 주식 수에 비해 미미하지만 내부자의 신뢰가 점진적으로 증가하고 있음을 시사할 수 있습니다. 이번 보고서에서는 중요한 전략적 변화, 옵션 행사 또는 복잡한 헤징 수단에 대한 징후는 없습니다.

Activité des initiés Formulaire 4 – Exelon Corporation (EXC) : Le 30/06/2025, le directeur Bryan K. Segedi a acquis 954 unités d’actions différées d’actions ordinaires Exelon au prix de 43,25$ chacune via le Plan d’Unités d’Actions Différées pour les Administrateurs d’Exelon Corp. Cet achat a porté ses avoirs indirects à 6 483 unités, chiffre incluant déjà 51 actions accumulées par réinvestissement des dividendes. Aucune action n’a été vendue et aucune position sur dérivés n’a été déclarée.

La transaction est estimée à environ 41 000$, ce qui est négligeable par rapport au nombre total d’actions d’Exelon, mais pourrait indiquer une confiance accrue des initiés. Aucun signe de changements stratégiques majeurs, d’exercices d’options ou d’instruments de couverture complexes n’apparaît dans ce dépôt.

Formular 4 Insider-Aktivität – Exelon Corporation (EXC): Am 30.06.2025 erwarb Direktor Bryan K. Segedi 954 aufgeschobene Aktienanteile von Exelon-Stammaktien zu je 43,25$ über den Exelon Corp. Directors Deferred Stock Unit Plan. Der Kauf erhöhte seine indirekten Bestände auf 6.483 Einheiten, wobei bereits 51 Aktien durch Dividenden-Reinvestitionen enthalten sind. Es wurden keine Aktien verkauft und keine Derivatpositionen gemeldet.

Die Transaktion hat einen Wert von etwa 41.000$, was im Verhältnis zur Gesamtzahl der Exelon-Aktien unerheblich ist, aber auf ein zunehmendes Insidervertrauen hinweisen könnte. Es gibt keine Hinweise auf bedeutende strategische Veränderungen, Optionsausübungen oder komplexe Absicherungsinstrumente in dieser Meldung.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Segedi Bryan K

(Last) (First) (Middle)
10 S DEARBORN STREET
54TH FLOOR

(Street)
CHICAGO IL 60603

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EXELON CORP [ EXC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock- deferred stock units 06/30/2025 A 954 A $43.25 6,483(1) I By Exelon Corp. Directors Deferred Stock Unit Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Balance includes 51 additional shares acquired through automatic dividend reinvestment.
Remarks:
David T Skinner, attorney-in-fact for Bryan K Segedi 07/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Exelon (EXC) shares did director Bryan Segedi acquire?

He acquired 954 deferred stock units on 06/30/2025.

At what price were the deferred stock units acquired?

The units were recorded at $43.25 per share.

What is Bryan Segedi’s total indirect ownership after the transaction?

He now indirectly holds 6,483 deferred stock units via the director plan.

Does the Form 4 show any insider sales or option exercises?

No, the filing reports only an acquisition; there were no sales or derivative exercises.

Why are these units recorded as indirect ownership?

The shares reside within the Exelon Corp. Directors Deferred Stock Unit Plan, classifying them as indirect holdings.

Is this insider purchase material to Exelon’s share count?

No, the 954 units are immaterial relative to Exelon’s large outstanding share base.
Exelon

NASDAQ:EXC

EXC Rankings

EXC Latest News

EXC Latest SEC Filings

EXC Stock Data

42.92B
1.01B
0.12%
86.27%
2.01%
Utilities - Regulated Electric
Electric & Other Services Combined
Link
United States
CHICAGO